Advocate
Resource hub for advocacy materials developed by partner organizations that can be adapted and used by advocates for local campaigns in their own contexts. Campaigns include ongoing efforts that aim to expand affordable treatment and diagnostics access for all who need it. The section includes sign-on letters, petitions, and collective statements.
Latest publications
-
WE NEED A COMPREHENSIVE HEPATITIS C PACKAGE OF SERVICES FOR PEOPLE WHO USE AND INJECT DRUGS! “It’s been more than 5 years since we cured hepatitis C...where’s my package?”
Achieving hepatitis C virus (HCV) elimination by 2030 depends on how countries fund prevention, testing, treatment, and care and how they include HCV in efforts for universal health coverage. Investing in elimination requires national programs to provide services for key populations, (...) More
-
Have a heart, save my liver! Where are my diagnostics?
Of the 71 million people living with chronic hepatitis C, only ≈20% are aware of their status and less than 5% of people living in LMICs have been diagnosed.
We need simpler & cheaper tests to scale up diagnosis! More
Campaigns
Resource hub for advocacy materials developed by partner organizations that can be adapted and used by advocates for local campaigns in their own contexts. Campaigns include ongoing efforts that aim to expand affordable treatment and diagnostics access for all who need it. The section includes sign-on letters, petitions, and collective statements. More
-
Global Declaration to Eliminate Hepatitis C in People Who Use Drugs: A call for political leaders to take action
Sign the pledge! If elimination by 2030 is to be achieved, the global community needs to act immediately. More
-
WORLD HEPATITIS SUMMIT: NO ELIMINATION WITHOUT DECRIMINALIZATION! 18 civil society organisations call world leaders to promote harm reduction and decriminalise drug use
São Paulo, Brazil – November 2nd 2017.
At the occasion of the World Hepatitis Summit, a large coalition of patients, clinicians, social workers, representatives of the drug using community, researchers, and public health experts express their whole-hearted support to the commitment of the World (...) More -
Equitable access to HCV drugs
Petition to stop Gilead’s anti-diversion program that violates physician and patient rights to protect its profit. More
Advocacy tools
Resource hub for advocacy materials developed by partner organizations that can be adapted and used by advocates for local campaigns in their own contexts. Campaigns include ongoing efforts that aim to expand affordable treatment and diagnostics access for all who need it. The section includes sign-on letters, petitions, and collective statements. More
-
PEPFAR Watch!—Resource Tools for Funding Advocacy
The global grassroots organization, Health Global Access Project (Health GAP), convenes and coordinates PEPFAR Watch—global network holding the U.S. President’s Emergency Plan For AIDS Relief (PEPFAR) program accountable for delivery of quality, accessible HIV treatment and prevention. PEPFAR is (...) More
-
Migrants’ Inclusion Central to Achieving HIV and Hepatitis C Targets by 2030
In July 2018, the European African Treatment Advocates Network (EATAN), in partnership with Treatment Action Group (TAG) and other migrant-focused organizations, hosted the first European African HIV & Hepatitis C Virus (HCV) Community Summit. The Summit was organized as an AIDS 2018 (...) More
-
About mapCrowd
Worldwide, an estimated 71 million people are chronically infected with the hepatitis C virus (HCV). Obtaining reliable, update-to-date information on HCV is a major challenge for health experts and HCV advocates. The quantity and quality of data on HCV prevalence, access to prevention tools, (...) More